Moxetumomab Pasudotox

Category: Cancer

Moxetumomab Pasudotox Overview

Moxetumomab pasudotox, sold under the brand name Lumoxiti, is an anti-CD22 immunotoxin medication for the treatment of adults with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.[2][3][4] Moxetumomab pasudotox is a CD22-directed cytotoxin and is the first of this type of treatment for adults with HCL.[4] The drug consist...

Read more Moxetumomab Pasudotox Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Moxetumomab Pasudotox Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Moxetumomab Pasudotox
  • Injection: 1mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Moxetumomab Pasudotox or a similar ingredient: (1 result)